论文部分内容阅读
目的观察血塞通联合奥扎格雷钠治疗脑梗死的疗效分析。方法选择在我院收治的脑梗死患者72例,随机分为两组。所有患者均给予脑梗死常规基础治疗,对照组患者在常规治疗的基础上给予奥扎格雷钠80mg加入250ml的0.9%生理盐水中,2次/日,静脉滴注;治疗组在对照组治疗的基础上加用血塞通500mg加入250ml的5%葡萄糖液中,1次/日,静脉滴注。两组患者均治疗14天。结果治疗组治疗后的ESS和ADL与治疗前相比较,有显著差异(P<0.01),对照组治疗后的ESS和ADL与治疗前相比较,亦有明显改善(P<0.01);治疗后在ESS和ADL指标两组组间比较,治疗组明显优于对照组(P<0.01)。结论血塞通联合奥扎格雷钠治疗脑梗死,可以明显促进患者康复。
Objective To observe the efficacy of Xuesaitong combined with ozagrel sodium in the treatment of cerebral infarction. Methods 72 patients with cerebral infarction admitted to our hospital were randomly divided into two groups. All patients were given routine basic treatment of cerebral infarction. The patients in the control group were given Ozagrel sodium 80mg in 250ml of 0.9% saline on the basis of routine treatment. The patients in the control group were treated with intravenous drip twice daily, On the basis of adding 500mg Xuesaitong added 250ml of 5% glucose solution, 1 / day, intravenous infusion. Both groups were treated for 14 days. Results After treatment, the ESS and ADL in the treatment group were significantly different from those before treatment (P <0.01). The levels of ESS and ADL in the control group were also significantly improved after treatment (P <0.01) ESS and ADL indicators between the two groups, the treatment group was significantly better than the control group (P <0.01). Conclusion Xuesaitong combined with ozagrel sodium in the treatment of cerebral infarction, can significantly promote the recovery of patients.